Cited by 174Pregnancy and preeclampsia studiesMicroRNA in disease regulationNeurological Complications and Syndromes

Hydroxysteroid (17-β) Dehydrogenase 1 Is Dysregulated by Mir-210 and Mir-518c That Are Aberrantly Expressed in Preeclamptic Placentas: A Novel Marker for Predicting Preeclampsia

Ishibashi, Osamu, Ohkuchi, Akihide, Ali, Md. Moksed, Kurashina, Ryuhei, Luo, Shan-Shun, Ishikawa, Tomoko, Takizawa, Takami, Hirashima, Chikako +9 more·2012·Hypertension

Abstract

In this study, to search for novel preeclampsia (PE) biomarkers, we focused on microRNA expression and function in the human placenta complicated with PE. By comprehensive analyses of microRNA expression, we identified 22 microRNAs significantly upregulated in preeclamptic placentas, 5 of which were predicted in silico to commonly target the mRNA encoding hydroxysteroid (17-β) dehydrogenase 1 (HSD17B1), a steroidogenetic enzyme expressed predominantly in the placenta. In vivo HSD17B1 expression, at both the mRNA and protein levels, was significantly decreased in preeclamptic placentas. Of these microRNAs, miR-210 and miR-518c were experimentally validated to target HSD17B1 by luciferase assay, real-time PCR, and ELISA. Furthermore, we found that plasma HSD17B1 protein levels in preeclamptic pregnant women reflected the decrease of its placental expression. Moreover, a prospective cohort study of plasma HSD17B1 revealed a significant reduction of plasma HSD17B1 levels in pregnant women at 20 to 23 and 27 to 30 weeks of gestation before PE onset compared with those with normal pregnancies. The sensitivities/specificities for predicting PE at 20 to 23 and 27 to 30 weeks of gestation were 0.75/0.67 (cutoff value=21.9 ng/mL) and 0.88/0.51 (cutoff value=30.5 ng/mL), and the odds ratios were 6.09 (95% CI: 2.35–15.77) and 7.83 (95% CI: 1.70–36.14), respectively. We conclude that HSD17B1 is dysregulated by miR-210 and miR-518c that are aberrantly expressed in preeclamptic placenta and that reducing plasma level of HSD17B1 precedes the onset of PE and is a potential prognostic factor for PE.

Integrity signals

Registry

Crossref · 10.1161/hypertensionaha.111.180232

Cites

30 of 30 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • MiR-210 is increased in normal placentas from pregnancies at high altitude, and in placentas from pregnancies complicated by pre-eclampsia.

    “It is increased in normal placentas from pregnancies at high altitude (121), and in placentas from pregnancies complicated by pre-eclampsia (272, 351, 401, 611).”

    From Placental Origins of Chronic Disease (2016) · cites this paper as [272]

  • Other targets identified for miR-210 include the steroidogenic enzyme hydroxysteroid (17-ß) dehydrogenase 1, ephrin-A3 and homeobox-A9 which are involved in trophoblast cell migration and vascular remodeling, and thrombospondin type 1 domain containing 7A in the placental vasculature.

    “Besides mitochondria, other targets identified for miR-210 include the steroidogenic enzyme hydroxysteroid (17-ß) dehydrogenase 1 (272), ephrin-A3 and homeobox-A9 which are involved in trophoblast cell migration and vascular remodeling (611), and thrombospondin type 1 domain containing 7A in the placental vasculature (351).”

    From Placental Origins of Chronic Disease (2016) · cites this paper as [272]

Cites

Flagged first, then by citations

1 of the 31 references couldn’t be matched to a known paper.

Cited by

Sorted by citations

Authors
Ishibashi, O., Ohkuchi, A., Ali, M. M., Kurashina, R., Luo, S.-S., Ishikawa, T., Takizawa, T., Hirashima, C., Takahashi, K., Migita, M., Ishikawa, G., Yoneyama, K., Asakura, H., Izumi, A., Matsubara, S., Takeshita, T., & Takizawa, T.
Affiliations
Jichi Medical University (JP)
Venue
Hypertension
Published
2012-02
Volume
59
Issue
2
Pages
265-273
ISSN
  • 0194-911X (ISSN-L)
  • 1524-4563
OpenAlex
W1987627565
Cited by
173
References
31
Citations by year
2026: 4 · 2025: 7 · 2024: 7 · 2023: 4 · 2022: 11 · 2021: 15 · 2020: 11 · 2019: 11 · 2018: 17 · 2017: 13 · 2016: 16 · 2015: 19 · 2014: 14 · 2013: 18 · 2012: 5
FWCI
15.24
Type
journal article
Language
en
Open access
closed
Locations
  • Hypertension (publishedVersion)
  • PubMed (publishedVersion)
Funders
  • Jichi Medical University
  • China Medical University
  • Japan Society for the Promotion of Science (22791554, 20390437, 23390386, 23592419)
  • RIKEN
Topics
  • Health Sciences › Medicine › Obstetrics and Gynecology › Pregnancy and preeclampsia studies
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › MicroRNA in disease regulation
  • Health Sciences › Medicine › Psychiatry and Mental health › Neurological Complications and Syndromes
Keywords
preeclampsia, HSD17B1, miR-210, microRNA, placenta, preeclampsia biomarkers, steroidogenesis, prognostic factors, microRNA target regulation
MeSH terms
Adult, Hypoxia, Cells, Cultured, Estradiol Dehydrogenases, Female, Humans, Placenta, Pre-Eclampsia, Predictive Value of Tests, Pregnancy, Pregnancy Complications, Cardiovascular, Pregnancy Trimester, Second, Pregnancy Trimester, Third, Prognosis, Prospective Studies, ROC Curve, Trophoblasts, Cohort Studies, Biomarkers, MicroRNAs

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review